Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats

BMC Cardiovascular Disorders

Volumn 2, Issue , 2002, Pages

  Theuer, Juergen ^a   Dechend, Ralf ^a   Muller, Dominik ^a   Park, Joon Keun ^b   Fiebeler, Anette ^b   Barta, Peter ^a   Ganten, Detlev ^a   Haller, Hermann ^b   Dietz, Reiner ^a   Luft, Friedrich C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN; ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PYRROLIDINE DITHIOCARBAMATE; RENIN; SYNAPTOTAGMIN; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1; ANGIOTENSIN II; ANGIOTENSINOGEN; DRUG DERIVATIVE; ENZYME INHIBITOR; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; NOS2A PROTEIN, HUMAN; PROLINE; PROLINEDITHIOCARBAMATE; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DEATH; DISEASE SEVERITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GLOMERULUS; HEART BLOOD VESSEL; HEART HYPERTROPHY; HEART INJURY; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEMOLYTIC UREMIC SYNDROME; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY BLOOD VESSEL; KIDNEY COLLECTING TUBULE; KIDNEY INJURY; LEUKOCYTE MIGRATION; MALE; MYOCARDITIS; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEINURIA; RAT; SMOOTH MUSCLE FIBER; TRANSGENIC ANIMAL; UPREGULATION; ANIMAL; CARDIOMEGALY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; HEART; HUMAN; KIDNEY; METABOLISM; NECROSIS; OXIDATIVE STRESS; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARDIOMEGALY; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INHIBITORS; HEART; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; MODELS, ANIMAL; MYOCARDITIS; NECROSIS; NEPHRITIS; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; RENIN; THIOCARBAMATES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 3042594445     PISSN: 14712261     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2261-2-3     Document Type: Article

References (41)

1. Luft FC, Mervaala E, Muller DN, Gross V, Schmidt F, Park JK, Schmitz C, Lippoldt A, Breu V, Dechend R, Dragun D, Schneider W, Ganten D, Haller H: Hypertension-induced end-organ damage : A new transgenic approach to an old problem. Hypertension 1999, 33:212-218
2. Li C, Xu Q: Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal 2000, 12:435-445
3. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, Suematsu M, Zweifach BW, Schmid-Schonbein GW: Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A. 1998, 95:4754-4759
4. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M: Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2000, 20:2175-2183
5. Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kubler W: Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999, 19:1623-1629
6. Berk BC, Corson MA: Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res 1997, 80:607-616
7. Muller DN, Mervaala EM, Dechend R, Fiebeler A, Park JK, Schmidt F, Theuer J, Breu V, Mackman N, Luther T, Schneider W, Gulba D, Ganten D, Haller H, Luft FC: Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. Am J Pathol. 2000, 157:111-122
8. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC: NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension. 2000, 35:193-201
9. Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N-Engl-J-Med. 1997, 336:1066-1071
10. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, Taylor WR, Griendling KK: Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998, 32:488-495
11. Sen CK, Packer L: Antioxidant and redox regulation of gene transcription [see comments]. FASEB-J. 1996, 10:709-720
12. Hernandez Presa MA, Bustos C, Ortego M, Tunon J, Ortega L, Egido J: ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis. Am-J-Pathol. 1998, 153:1825-1837
13. Ruiz-Ortega M, Bustos C, Hernandez-Presa M, Lorenzo O, Plaza J, Edigo J: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kB activation and monocyte chemoattractant protein-1 synthesis. J. Immunol. 1998, 161:430-439
14. Liu S, Ye X, Malik A: Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation 1999, 100:1330-1337
15. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J-Exp-Med 1992, 175:1181-1194
16. Mervaala EM, Muller DN, Park JK, Schmidt F, Lohn M, Breu V, Dragun D, Ganten D, Haller H, Luft FC: Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 1999, 33:389-395
17. Muller DN, Luft FC: The renin-angiotensin system in the vessel wall. Basic Res Cardiol. 1998, 93:7-14
18. Altura BM, Gebrewold A: Pyrrolidine dithiocarbamate attenuates alcohol-induced leukocyte-endothelial cell interaction and cerebral vascular damage in rats: possible role of activation of transcription factor NF-kappaB in alcohol brain pathology. Alcohol. 1998, 16:25-28
19. Rangan GK, Wang Y, Tay YC, Harris DC: Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kidney-Int 1999, 56:118-134
20. Dragun D, Tullius SG, Park JK, Maasch C, Lukitsch I, Lippoldt A, Gross V, Luft FC, Haller H: ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int 1998, 54:590-602
21. Mervaala EMA, Muller DN, Park J-K, Schmidt F, Breu V, Dragun D, Ganten D, Haller H, Luft FC: Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 1999, 33:389-395
22. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, Juepner A, Gulba DC, Mackman N, Haller H, Luft FC: AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 2000, 101:2382-2387
23. Dechend R, Hirano F, Lehmann K, Heissmeyer V, Ansieau S, Wulczyn FG, Scheidereit C, Leutz A: The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene 1999, 18:3316-3323
24. Zabel U, Henkel T, Silva MS, Baeuerle PA: Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus. EMBO-J. 1993, 12:201-211
25. Luft FC: Workshop: mechanisms and cardiovascular damage in hypertension. Hypertension. 2001, 37:594-598
26. Griendling KK, Ushio-Fukai M: Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000, 91:21-27
27. Touyz RM, Schiffrin EL: Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999, 34:976-982
28. Dechend R, Maass M, Gieffers J, Dietz R, Scheidereit C, Leutz A, Gulba DC: Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation. 1999, 100:1369-1373
29. Wulczyn FG, Krappmann D, Scheidereit C: The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation. J Mol Med. 1996, 74:749-769
30. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-kB. Ann Rev Cell Biol. 1994, 10:405-455
31. Luft FC, Mervaala EMA, Muller DN, Gross V, Park J-K, Schmitz C, Lippold A, Breu V, Dragun D, Dechend R, Schneider W, Ganten D, Haller H: Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension. 1999, 33:212-218
32. Munoz C, Castellanos MC, Alfranca A, Vara A, Esteban MA, Redondo JM, de Landazuri MO: Transcriptional up-regulation of intracellular adhesion molecule-1 in human endothelial cells by the antioxidant pyrrolidine dithiocarbamate involves the activation of activating protein-1. J-Immunol. 1996, 157:3587-3597
33. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, Namba M: Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 1998, 98:794-799
34. Morrissey JJ, Klahr S: Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney-Int. 1997, 52:926-933
35. Lenardo MJ, Baltimore D: NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989, 58:227-229
36. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T: In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997, 3:894-899
37. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney-Int 1997, 51:2-15
38. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. New Engl J Med. 1998, 339:1448-1456
39. Perrella MA, Patterson C, Tan L, Yet SF, Hsieh CM, Yoshizumi M, Lee ME: Suppression of interleukin-1beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-beta1 in vascular smooth muscle cells. Evidence for mechanisms other than NF-kappaB. J-Biol-Chem. 1996, 271:13776-13780
40. Hobbs A, Higgs A, Moncada S: Inhibition of nitric oxide synthase as a potential therapeutic target. Annual Review Of Pharmacology And Toxicology. 1999, 39:191-200
41. Klahr S: The role of L-arginine in hypertension and nephrotoxicity. Current Opinion In Nephrology And Hypertension 1998, 7:547-550 7